18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy |
|
Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik |
|
App-controlled treatment monitoring and support for head and neck cancer patients (APCOT): protocol for a prospective randomized controlled trial |
|
Auswirkungen von Chemotherapeutika und Photonenbestrahlung auf mesenchymale Stammzellen |
|
Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes |
|
Changes in blood biomarkers of angiogenesis and immune modulation after radiation therapy and their association with outcomes in thoracic malignancies |
|
Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients |
|
Differential response of esophageal cancer cells to particle irradiation |
|
Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients |
|
Human mesenchymal stem cells are resistant to UV-B irradiation |
|
influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation |
|
Intraindividual comparison between [18F] PSMA-1007 PET/CT and multiparametric MRI for radiotherapy planning in primary prostate cancer patients |
|
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis |
|
Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites |
|
Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy |
|
Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : results of the NRG-HN002 trial |
|
Multipotent mesenchymal stromal cells are sensitive to thermic stress - potential implications for therapeutic hyperthermia |
|
Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients |
|
particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond? |
|
Patterns-of-Care analysis for radiotherapy of elderly head-and-neck cancer patients: a trinational survey in Germany, Austria and Switzerland |
|
Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany |
|
Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease |
|
Radiotherapeutic management of cervical lymph node metastases from an unknown primary site : experiences from a large cohort treated with modern radiation techniques |
|
Radiotherapy for nonagenarians: the value of biological versus chronological age |
|
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients |
|
Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer |
|
role of palliative radiotherapy in the treatment of spinal bone metastases from head and neck tumors - a multicenter analysis of a rare event |
|
SBRT von primären Nierenzellkarzinomen – Langzeitergebnisse der IROCK-Datenbank |
|
Stereotactic body radiotherapy for renal cell carcinoma in patients with von Hippel–Lindau disease - results of a prospective trial |
|
value of laboratory parameters for anemia, renal function, systemic inflammation and nutritional status as predictors for outcome in elderly patients with head-and-neck cancers |
|
value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer |
|
value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation |
|
value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly |
|
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial |
|